CollPlant Biotechnologies Ltd. (CLGN)
4.19
+0.08
(+1.95%)
USD |
NASDAQ |
Nov 04, 13:58
CollPlant Biotechnologies Price : 4.19 for Nov. 4, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 03, 2026 | 4.01 | 4.440 | 3.99 | 4.11 | 22970.00 |
| Nov 02, 2026 | 4.15 | 4.20 | 3.95 | 4.08 | 40495.00 |
| Oct 30, 2026 | 4.20 | 4.60 | 4.10 | 4.135 | 44248.00 |
| Oct 29, 2026 | 4.10 | 4.70 | 3.870 | 4.40 | 167097.0 |
| Oct 28, 2026 | 3.87 | 4.00 | 3.75 | 3.95 | 9250.00 |
| Oct 27, 2026 | 3.78 | 3.96 | 3.63 | 3.90 | 38040.00 |
| Oct 26, 2026 | 3.67 | 3.91 | 3.65 | 3.75 | 33810.00 |
| Oct 23, 2026 | 3.60 | 3.72 | 3.52 | 3.67 | 12096.00 |
| Oct 22, 2026 | 3.71 | 3.74 | 3.41 | 3.62 | 10600.00 |
| Oct 21, 2026 | 3.80 | 3.81 | 3.551 | 3.755 | 9684.00 |
| Oct 20, 2026 | 3.570 | 3.88 | 3.530 | 3.88 | 20357.00 |
| Oct 19, 2026 | 3.62 | 3.68 | 3.45 | 3.56 | 28971.00 |
| Oct 16, 2026 | 3.70 | 3.719 | 3.53 | 3.625 | 13437.00 |
| Oct 15, 2026 | 4.01 | 4.01 | 3.590 | 3.68 | 72293.00 |
| Oct 14, 2026 | 4.00 | 4.13 | 3.82 | 4.13 | 39863.00 |
| Oct 13, 2026 | 4.05 | 4.11 | 3.85 | 3.91 | 48005.00 |
| Oct 12, 2026 | 3.50 | 4.45 | 3.50 | 4.02 | 166792.0 |
| Oct 09, 2026 | 3.88 | 4.126 | 3.51 | 3.51 | 182346.0 |
| Oct 08, 2026 | 3.49 | 4.16 | 3.31 | 3.97 | 57508.00 |
| Oct 07, 2026 | 3.35 | 3.585 | 3.31 | 3.46 | 23057.00 |
| Oct 06, 2026 | 3.39 | 3.490 | 3.25 | 3.39 | 25025.00 |
| Oct 05, 2026 | 3.49 | 3.67 | 3.401 | 3.41 | 7515.00 |
| Oct 02, 2026 | 3.62 | 3.62 | 3.30 | 3.46 | 45497.00 |
| Oct 01, 2026 | 3.84 | 3.84 | 3.55 | 3.57 | 26269.00 |
| Sep 30, 2026 | 3.825 | 3.83 | 3.70 | 3.78 | 10928.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 20.41 |
| Perspective Therapeutics, Inc. | 0.8996 |
| MiMedx Group, Inc. | 3.23 |
| Regentis Biomaterials Ltd. | 1.37 |
| Xylo Technologies Ltd. | 5.07 |
Price Related Metrics
| PS Ratio | 134.12 |
| PEG Ratio | -0.0118 |
| Price to Book Value | 2.055 |
| Earnings Yield | -62.99% |
| Market Cap | 6.052M |
| PEGY Ratio | -0.0118 |